Figure 2
Comparison of HCV viral load in RA patients receiving different treatments. Tofa, tofacitinib; RTX, rituximab; TNFi, tumor necrosis factor-α inhibitor; HCV, hepatitis C virus. Data are presented as the mean ± SD. *P < 0.05.
Figure 2 | Scientific Reports
